Literature DB >> 16847447

Detrimental antidepressant drug-drug interactions: are they clinically relevant?

Sheldon Preskorn1, Steve Werder.   

Abstract

This paper takes the position that detrimental drug-drug interactions (DDIs) involving antidepressants are clinically relevant. In doing so, it begins with a definition of the terms: drug-drug interaction, detrimental, and clinical relevance. It then discusses the issues of proof and provides an overview of the clinically relevant DDIs involving antidepressants. It also gives examples involving drugs besides antidepressants based on the premise that the underlying principles are applicable regardless of the therapeutic classes of the drugs involved.

Mesh:

Substances:

Year:  2006        PMID: 16847447     DOI: 10.1038/sj.npp.1301070

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  4 in total

Review 1.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

Review 2.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

3.  Evaluation of Potential Drug-Drug Interactions with Antidepressants in Two Tertiary Care Hospitals.

Authors:  Muhammad Salman Rafi; Syed Baqir Shyum Naqvi; Muhammad Umair Khan; Muhammad Fayyaz; Nida Ashraf; Maqsood Ahmed Khan; Akram Ahmad; Sameer Dhingra
Journal:  J Clin Diagn Res       Date:  2015-07-01

Review 4.  Antidepressants- and antipsychotics-induced hepatotoxicity.

Authors:  Nevena Todorović Vukotić; Jelena Đorđević; Snežana Pejić; Neda Đorđević; Snežana B Pajović
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.